Hypera S.A. (OTCMKTS:HYPMY – Get Free Report)’s share price reached a new 52-week low on Friday . The company traded as low as $3.60 and last traded at $3.64, with a volume of 66404 shares trading hands. The stock had previously closed at $3.73.
Hypera Stock Down 2.3 %
The stock has a market cap of $2.31 billion, a price-to-earnings ratio of 7.00 and a beta of 1.06. The business’s 50 day simple moving average is $4.78 and its 200 day simple moving average is $5.21.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Further Reading
- Five stocks we like better than Hypera
- How to Use Stock Screeners to Find Stocks
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- Options Trading – Understanding Strike Price
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- How to Capture the Benefits of Dividend Increases
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
